Delivery Order SPE2DB25D3201-SPE2DB25FNUKA
Award Date
7/2/25
Potential Completion Date
7/24/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML. The contract has a ceiling value of $33,253.00 and a period of performance through July 28, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,253.40, is for the supply of 1,500 units of the medication KEDRAB, a 10 ML vial. The contract has a firm fixed price pricing type and a period of performance through April 11, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KEDRAB, a 1,500 unit/10 ml vial of a pharmaceutical product. The contract has a ceiling value of $1,626.70 and is a firm fixed price, non-set-aside contract with a performance period ending on May 19, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite...
This is a $3,325.30 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KEDRAB 300 UNIT/2 ML VIAL 2ML, a pharmaceutical product, with a period of performance through July 2, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,891.24 fixed-price contract is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The contract has an ultimate completion date of October 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KEDRAB 150 U/ML VL 1S, a medical product. The contract has a ceiling value of $10,308.43 and a period of performance ending on July 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 1,500 units of the pharmaceutical product KEDRAB 10 ML vial. The contract has a ceiling value of $3,253.40 and a period of performance through July 24, 2025. The contract is not set aside and was awarded on July 2, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of KEDRAB, a 300 unit/2 ml vial medication. The $3,990.36 firm fixed price delivery order contract has a completion date of June 25, 2025 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML, a medical product. The total ceiling value of the contract is $1,995.18, and it is structured as a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. The place of performance is Conshohocken, PA....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of KEDRAB, a 300 unit/2 ml vial medication, at a ceiling value of $1,297.08. The contract has a firm fixed price and an ultimate completion date of September 24, 2024. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription drugs,...